Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition) ›› 2020, Vol. 06 ›› Issue (06): 364-369. doi: 10.3877/cma.j.issn.2096-0263.2020.06.009

Special Issue:

• Review • Previous Articles     Next Articles

Comparison and prospect of different mesenchymal stem cells in the treatment of early osteoarthritis

Zhiwei Wang1, Haiqiang Suo1, Hanguang Liang1, Junting Zang1, Wei Feng1,()   

  1. 1. Department of Orthopedics, the First Bethune Hospital of Jilin University, Changchun 130000, China
  • Received:2019-10-23 Online:2020-12-05 Published:2020-12-05
  • Contact: Wei Feng
  • About author:
    Corresponding author: Feng Wei, Email:

Abstract:

Osteoarthritis (OA) is one of the common joint diseases with major pathological changes such as articular cartilage degeneration, subchondral bone remodeling, joint space narrowing and marginal osteophyte proliferation. With the continuous progress of research on OA treatment, the prospect of the stem cells has been widely recognized. Mesenchymal stem cells include bone marrow mesenchymal stem cells, adipose derived stem cell, synovial mesenchymal stem cells and peripheral blood mesenchymal stem cells, umbilical cord blood mesenchymal stem cells. Mesenchymal stem cells from different sources have their own characteristics in the treatment of osteoarthritis.

Key words: Mesenchymal stem cells, Osteoarthritis, Comparison

京ICP备07035254号-18
Copyright © Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), All Rights Reserved.
Tel: 0311-88603818 E-mail: zhlngkykf@126.com
Powered by Beijing Magtech Co. Ltd